NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-061-2018-0-US-01 EBOLA VIRUS GLYCOPROTEIN-SPECIFIC MONOCLONAL ANTIBODIES AND USES THEREOF US 62/782,809 Abandoned
NCATS E-074-2019-0-US-01 NS-1 Inhibitors For The Treatment Of Flavivirus Infections US 62/781,987 Abandoned
NICHD E-247-2009-2-US-09 Dendrimer Based Nanodevices For Therapeutic And Imaging Purposes US CON 16/223,793 10561673 Issued PDF
NCI E-223-2017-0-PCT-02 CHEMICAL ENTITIES FOR LYTIC ACTIVATION OF KSHV AND THERAPEUTIC TARGETING OF VIRAL ENZYMES/PROTEINS PCT PCT PCT/US2018/065601 Expired
NCI E-050-2014-0-SG-15 Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon SG DIV 10201811190S Pending
NCI E-494-2013-0-US-11 METHODS OF PREPARING ANTI-HUMAN PAPILLOMAVIRUS ANTIGEN T CELLS US CON 16/218,658 Abandoned
NCI E-025-2009-0-US-29 Ratio Based Biomarker Of Survival Utilizing PTEN And Phospho-AKT US CON 16/217,540 11237169 Issued PDF
NCI E-053-2015-1-US-04 MYC G-QUADRUPLEX STABILIZING SMALL MOLECULES AND THEIR USE US DIV 16/218,341 10604499 Issued PDF
NCI E-133-2016-0-EP-03 FLT3-Specific Chimeric Antigen Receptors and Methods Using Same EP National Stage 17729627.4 Pending
NIAID E-007-2015-0-US-16 CD47-targeted Therapies For The Treatment Of Infectious Disease US CON 16/214,507 10723803 Issued PDF
NIDDK E-022-2019-0-US-01 A1 ADENOSINE RECEPTOR AGONISTS AND METHODS OF USE THEREOF US 62/776,528 Abandoned
NCI E-114-2011-0-US-05 METHODS OF GROWING TUMOR INFILTRATING LYMPHOCYTES IN GAS-PERMEABLE CONTAINERS US CON 16/211,859 11401503 Issued PDF
NCI E-289-2011-0-US-02 YEAST-MUC1 IMMUNOTHERAPEUTIC COMPOSITIONS AND USES THEREOF US CON 16/211,492 11065318 Issued PDF
CC E-114-2016-0-US-03 TISSUE CHARACTERIZATION WITH ACOUSTIC WAVE TOMOSYNTHESIS US National Stage 16/307,925 Abandoned
NIAID E-034-2018-1-US-01 NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE US 62/775,754 Abandoned
NHLBI E-201-2016-0-KR-06 Annuloplasty Procedures, Related Devices And Methods KR National Stage 10-2018-7035352 Pending
NCI E-171-2018-7-HK-08 MODIFIED CELLS AND METHODS OF THERAPY HK EP 18115478.9 Issued
NCI E-059-2013-0-AU-12 Methods of Producing Enriched Populations of Tumor-Reactive T Cells From Tumor AU DIV 2018274874 Issued
NHLBI E-156-2016-0-EP-05 ADENO-ASSOCIATED VIRUS POLYNUCLEOTIDES, POLYPEPTIDES AND VIRIONS EP National Stage 17793239.9 Issued
NINR E-223-2018-1-PCT-01 Rapid Nucleic Acids Preparation/Sample Preparation Via Hollow Centere Silica Microsphere PCT PCT COMB PCT/US2018/063663 Expired
NCI E-239-2017-0-EP-09 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS EP National Stage 18830062.8 Pending
NCI E-239-2017-0-SG-16 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS SG National Stage 11202005236Q Pending
NCI E-239-2017-0-KR-13 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS KR National Stage 2020-7019185 Pending
NCI E-239-2017-0-CR-07 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS CR National Stage 2020-0287 Pending
NCI E-239-2017-0-CN-06 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS CN National Stage 201880087270.7 Pending
NCI E-239-2017-0-CA-05 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS CA National Stage 3084246 Pending
NCI E-239-2017-0-MX-14 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS MX National Stage MX/a/2020/005765 Pending
NCI E-239-2017-0-PCT-02 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS PCT PCT PCT/US2018/063581 Expired
NCI E-238-2017-0-PCT-02 METHODS OF ENRICHING CELL POPULATIONS FOR CANCER-SPECIFIC T CELLS USING IN VITRO STIMULATION OF MEMORY T CELLS PCT PCT PCT/US2018/063563 Expired
NCI E-239-2017-0-AU-03 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS AU National Stage 2018378200 Pending
NCI E-239-2017-0-BR-04 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS BR National Stage BR112020011111-2 Pending
NCI E-239-2017-0-IL-10 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS IL National Stage 275031 Pending
NCI E-239-2017-0-IN-11 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS IN National Stage 202047026991 Pending
NCI E-040-2012-0-IL-30 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen IL DIV 263417 Issued
NCI E-162-2014-0-IT-24 HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE IT EP 18209632.1 Issued
NCI E-162-2014-0-EP-17 HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE EP DIV 18209632.1 Issued
NCI E-162-2014-0-ES-21 HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE ES EP 18209632.1 Issued
NCI E-162-2014-0-CH-19 HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE CH EP 18209632.1 Issued
NCI E-162-2014-0-GB-23 HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE GB EP 18209632.1 Issued
NCI E-162-2014-0-BE-18 HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE BE EP 18209632.1 Issued
NCI E-162-2014-0-NL-25 HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE NL EP 18209632.1 Issued
NCI E-162-2014-0-DE-20 HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE DE EP 18209632.1 Issued
NCI E-162-2014-0-FR-22 HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE FR EP 18209632.1 Issued
NCI E-176-2014-0-US-15 ANTI-HUMAN PAPILLOMAVIRUS 16 E7 T CELL RECEPTORS US DIV 16/205,631 10870687 Issued PDF
NCI E-127-2018-0-US-01 Compositions and Methods for Treating Cancer with Anti-CD38 Immunotherapy US 62/773,940 Abandoned
NICHD E-003-2018-1-PCT-01 AUTOPHAGY MODULATORS FOR USE IN TREATING CANCER PCT PCT COMB PCT/US2018/062866 Expired
NCI E-137-2016-0-PCT-02 MICROBICIDAL COMPOSITION PCT PCT PCT/US2018/062857 Expired
NIAMS E-024-2018-0-PCT-02 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING AND/OR PREVENTING PERIODONTAL DISEASE PCT PCT PCT/US2018/062593 Expired
NIAMS E-024-2018-0-CN-03 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING AND/OR PREVENTING PERIODONTAL DISEASE CN National Stage 201880076753.7 Pending
NIAMS E-024-2018-0-EP-04 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING AND/OR PREVENTING PERIODONTAL DISEASE EP National Stage 18816451.1 Pending